Moody National Bank Trust Division Boosts Position in Intuitive Surgical, Inc. $ISRG

Moody National Bank Trust Division lifted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 40.8% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 5,924 shares of the medical equipment provider’s stock after buying an additional 1,716 shares during the quarter. Moody National Bank Trust Division’s holdings in Intuitive Surgical were worth $2,409,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently modified their holdings of the company. Motiv8 Investments LLC acquired a new position in shares of Intuitive Surgical during the 4th quarter valued at $34,000. Main Street Group LTD bought a new stake in Intuitive Surgical in the first quarter valued at $30,000. Vermillion Wealth Management Inc. increased its stake in Intuitive Surgical by 58.1% in the first quarter. Vermillion Wealth Management Inc. now owns 68 shares of the medical equipment provider’s stock valued at $31,000 after purchasing an additional 25 shares in the last quarter. Evergreen Advisors LLC acquired a new position in shares of Intuitive Surgical during the first quarter valued at about $35,000. Finally, Compass Financial Management LLC acquired a new position in shares of Intuitive Surgical during the second quarter valued at about $30,000. Institutional investors own 83.64% of the company’s stock.

Trending Headlines about Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Artificial intelligence could support Intuitive Surgical’s long-term growth by improving surgical planning, workflow efficiency and clinical data analysis. However, adoption, regulation and execution remain important uncertainties. 3 Medical Instruments Stocks Using GenAI to Navigate Industry Woes
• Positive Sentiment: A recent investment analysis argues that Intuitive’s valuation multiple has contracted while the underlying business story remains intact. The company’s earnings growth, recurring instrument and accessory revenue, and continued adoption of robotic-assisted surgery could provide support if procedure volumes accelerate. Intuitive Surgical: The Multiple Fell, The Story Didn’t
• Neutral Sentiment: The broader medical-instruments outlook places ISRG alongside Globus Medical and Thermo Fisher Scientific, highlighting artificial intelligence as a potential growth avenue while noting that industry conditions and regulatory developments will influence commercialization. Zacks Industry Outlook Globus Medical, Intuitive Surgical and Thermo Fisher Scientific
• Negative Sentiment: ISRG has decreased 8.2% over the past year, significantly underperforming the S&P 500. The stock’s valuation remains demanding at roughly 46 times earnings, and it trades below its 200-day moving average, leaving investors focused on whether new system placements, procedure growth and recurring revenue can justify a rebound. What Could Lift ISRG Stock?

Wall Street Analyst Weigh In

Several analysts have recently commented on ISRG shares. KeyCorp restated an “overweight” rating on shares of Intuitive Surgical in a research note on Wednesday, August 12th. Stifel Nicolaus dropped their price target on Intuitive Surgical from $670.00 to $550.00 and set a “buy” rating on the stock in a research note on Friday, July 17th. Piper Sandler reiterated an “overweight” rating on shares of Intuitive Surgical in a report on Friday, August 21st. BMO Capital Markets reissued an “outperform” rating on shares of Intuitive Surgical in a research note on Monday, July 20th. Finally, BNP Paribas Exane upgraded Intuitive Surgical to an “outperform” rating in a report on Tuesday, July 28th. Twenty-two analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus target price of $502.53.

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG traded down $1.72 during midday trading on Tuesday, hitting $404.76. 1,649,590 shares of the company’s stock were exchanged, compared to its average volume of 2,425,763. Intuitive Surgical, Inc. has a 12 month low of $328.57 and a 12 month high of $603.88. The company has a market cap of $142.99 billion, a PE ratio of 46.36, a price-to-earnings-growth ratio of 2.96 and a beta of 1.46. The stock has a 50 day moving average price of $381.62 and a 200-day moving average price of $412.58.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share for the quarter, beating the consensus estimate of $2.48 by $0.32. The business had revenue of $2.89 billion for the quarter, compared to analysts’ expectations of $2.83 billion. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The firm’s revenue for the quarter was up 18.4% compared to the same quarter last year. During the same quarter last year, the firm earned $1.81 EPS. On average, analysts anticipate that Intuitive Surgical, Inc. will post 8.87 EPS for the current fiscal year.

Insider Buying and Selling

In related news, VP Fredrik Widman sold 1,089 shares of the stock in a transaction on Tuesday, September 15th. The stock was sold at an average price of $374.44, for a total value of $407,765.16. Following the completion of the sale, the vice president directly owned 1,026 shares of the company’s stock, valued at approximately $384,175.44. This represents a 51.49% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gary S. Guthart sold 10,000 shares of the firm’s stock in a transaction on Tuesday, August 11th. The shares were sold at an average price of $400.00, for a total value of $4,000,000.00. Following the transaction, the director owned 1,245,679 shares in the company, valued at approximately $498,271,600. This trade represents a 0.80% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 12,370 shares of company stock valued at $4,891,989. 0.60% of the stock is currently owned by company insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops and commercializes robotic-assisted systems and related technologies designed to support minimally invasive medical procedures. The company’s products are intended to help surgeons perform operations through small incisions while providing enhanced visualization, precision, and control.

Its principal product is the da Vinci Surgical System, a platform used across a range of specialties, including general surgery, urology, gynecology, thoracic surgery, and cardiac procedures.